FDA panel recommends female condom approval; efficacy concerns remain.
D000569:Americas; D002986:Clinical Trials as Topic; D003257:Consumer Product Safety; D003267:Contraception; D003268:Contraception Behavior; D019049:Developed Countries; D003906:Developing Countries; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006077:Government Agencies; D015658:HIV Infections; D007239:Infections; D007843:Latin America; D007878:Legislation as Topic; D009656:North America; D009938:Organizations; D011057:Politics; D011639:Public Opinion; D012106:Research; D012749:Sexually Transmitted Diseases; D014481:United States; D014777:Virus Diseases; D014930:Women
Americas; Barrier Methods; Clinical Research; Clinical Trials; Contraception; Contraception Failure; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Usage; Critique; Developed Countries; Developing Countries; Diseases; Family Planning; Government Agencies; Hiv Infections--prevention and control; Infections; Interest Groups; Latin America; Legislation; North America; Northern America; Organizations; Political Factors; Product Approval; Reproductive Tract Infections; Research Methodology; Sexually Transmitted Diseases--prevention and control; United States; Vaginal Barrier Methods; Viral Diseases; Women's Groups